Carrier priming to improve pneumococcal disease control and reduce the international program’s cost in children [commentary] Read more about Carrier priming to improve pneumococcal disease control and reduce the international program’s cost in children [commentary]
Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction Read more about Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction2 views
Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: uncertain herd impact on pneumonia critical Read more about Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: uncertain herd impact on pneumonia critical2 views
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children Read more about Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children21 views
Pneumonia in elderly Australians – reduction in presumptive pneumococcal but no change in all cause pneumonia hospitalisations post 7 valent pneumococcal conjugate vaccine Read more about Pneumonia in elderly Australians – reduction in presumptive pneumococcal but no change in all cause pneumonia hospitalisations post 7 valent pneumococcal conjugate vaccine8 views
Long term population impact of seven-valent pneumococcal conjugate vaccine with a “3+0” schedule – how do “2+1” and “3+1” schedules compare? Read more about Long term population impact of seven-valent pneumococcal conjugate vaccine with a “3+0” schedule – how do “2+1” and “3+1” schedules compare?
Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings Read more about Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings
Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial Read more about Pneumococcal conjugate vaccines PREVenar13 and SynflorIX in sequence or alone in high-risk Indigenous infants (PREV-IX_COMBO): protocol of a randomised controlled trial77 views
Pneumococcal infections at Hajj: current knowledge gaps Read more about Pneumococcal infections at Hajj: current knowledge gaps
Pneumococcal vaccine uptake among Australian Hajj pilgrims in 2011–13 Read more about Pneumococcal vaccine uptake among Australian Hajj pilgrims in 2011–134 views